Follicular Lymphoma

• CLINICAL_TRIALS trial_result · 2016-11-21
  Clinical Trial Update: Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) [Phase 2]

  Phase 2 trial assessing blood stem cell transplant with low-dose chemotherapy for relapsed follicular non-Hodgkin's lymphoma (BMT CTN 0701) …

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial evaluating Rituximab (MabThera/Rituxan) in patients with non-bulky follicular non-Hodgkin's lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma [Phase 1]

  Phase 1 pharmacokinetic study comparing subcutaneous and intravenous rituximab in patients with follicular lymphoma to assess absorption and…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma [Phase 2]

  A Phase 2 clinical trial of rituximab (MabThera/Rituxan) in follicular lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

  An observational study of Rituximab (MabThera/Rituxan) in patients with follicular lymphoma has been terminated.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-10-25
  Clinical Trial Update: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]

  Clinical trial update on CD19-targeted CAR-T cell therapy being tested in relapsed/refractory leukemias and lymphomas (Phase 1 and Phase 2).

• CLINICAL_TRIALS trial_result · 2016-10-24
  Clinical Trial Update: Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Phase 2]

  A Phase 2 trial of fludarabine, bortezomib (Velcade), and rituximab for relapsed or refractory follicular lymphoma has been terminated, with…

• CLINICAL_TRIALS trial_result · 2016-08-12
  Clinical Trial Update: A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma

  A clinical trial evaluating rituximab in combination with chemotherapy for relapsed/refractory follicular lymphoma has completed and results…

• CLINICAL_TRIALS trial_result · 2016-08-01
  Clinical Trial Update: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]

  Clinical trial update for PCAR-019 evaluating efficacy and safety in CD19-positive relapsed or refractory leukemia and lymphoma across Phase…

• CLINICAL_TRIALS trial_result · 2016-07-22
  Clinical Trial Update: Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL) [Phase 2]

  Phase 2 clinical trial evaluating safety and efficacy of single-agent obatoclax mesylate followed by rituximab in previously untreated folli…

• CLINICAL_TRIALS trial_result · 2016-07-12
  Clinical Trial Update: Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma [Phase 2]

  Phase 2 trial evaluating low-dose methotrexate in combination with I-131 labeled tositumomab for previously untreated advanced-stage follicu…

• CLINICAL_TRIALS trial_result · 2016-07-01
  Clinical Trial Update: Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]

  The document reports the completion of a Phase 2 trial evaluating the combination of cyclophosphamide and filgrastim in patients with stage …

• CLINICAL_TRIALS trial_result · 2016-06-17
  Clinical Trial Update: Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma [Phase 2]

  Phase 2 trial evaluating Y-90 ibritumomab tiuxetan after R-CHOP chemotherapy in advanced-stage follicular lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2016-06-03
  Clinical Trial Update: Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma [Phase 2]

  Phase 2 trial evaluating CT-011 in combination with rituximab for relapsed follicular lymphoma has completed, with results posted in 2016.

• CLINICAL_TRIALS trial_result · 2016-04-25
  Clinical Trial Update: A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease [Phase 1]

  Phase 1 trial results for obinutuzumab in Chinese participants with CD20+ malignant disease. Diseases studied include chronic lymphocytic le…

• CLINICAL_TRIALS trial_result · 2016-04-04
  Clinical Trial Update: Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL) [Phase 2]

  This document provides an update on a Phase 2 trial evaluating rituximab with CVP chemotherapy plus interferon for follicular non-Hodgkin ly…

• CLINICAL_TRIALS trial_result · 2016-03-30
  Clinical Trial Update: A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]

  A completed Phase 1/2 clinical trial evaluating ocrelizumab in participants with follicular non-Hodgkin's lymphoma.

• CLINICAL_TRIALS trial_result · 2016-03-15
  Clinical Trial Update: A Phase I/II Trial of VR-CHOP in Lymphoma Patients [Phase 1, Phase 2]

  This clinical trial update reports results from a Phase I/II study of VR-CHOP in patients with B-cell non-Hodgkin lymphoma, including follic…

• CLINICAL_TRIALS trial_result · 2016-03-01
  Clinical Trial Update: Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma [Phase 2]

  This Phase 2 trial evaluated a chemoimmunotherapy regimen of rituximab, bendamustine, and mitoxantrone followed by rituximab in elderly pati…

• CLINICAL_TRIALS trial_result · 2016-02-25
  Clinical Trial Update: Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)

  Hoffmann-La Roche conducted a prospective observational study evaluating the management of patients with relapsed or refractory follicular l…

• CLINICAL_TRIALS trial_result · 2016-02-15
  Clinical Trial Update: A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) [Phase 2]

  Phase 2 pilot trial of oral vorinostat plus eltrombopag in lymphoma was terminated.

• CLINICAL_TRIALS trial_result · 2016-01-11
  Clinical Trial Update: Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta) [Phase 3]

  Phase 3 trial RoZetta comparing Rituximab versus Zevalin in follicular lymphoma was terminated with results posted in 2016.

• CLINICAL_TRIALS trial_result · 2016-01-08
  Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]

  Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.

• CLINICAL_TRIALS trial_result · 2015-12-22
  Clinical Trial Update: GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Phase 2]

  A Phase 2 trial evaluated GM-CSF and rituximab after autologous stem cell transplant in patients with relapsed or refractory follicular non-…

• CLINICAL_TRIALS trial_result · 2015-12-17
  Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating a radiolabeled monoclonal antibody with rituximab, with/without filgrastim and interleukin-11, in relapsed or r…